Industrial production method of azilsartan

A production method, the technology of candesartan, which is applied in the field of pharmaceutical production, can solve the problems that the cost and safety are not suitable for industrial production, cannot reach the medicinal level, and cannot be industrialized production, so as to achieve high economic value and social benefits, and increase the yield , The effect of reducing impurity B

Active Publication Date: 2014-02-26
合肥远志医药科技开发有限公司
View PDF10 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Chinese patent CN102344415A discloses that replacing hydroxylamine hydrochloride with 50% hydroxylamine solution can increase the yield, but the actual result still has a large amount of amide by-products, and the yield is about 51% to 55%. In addition, the 50% hydroxylamine solution is expensive and unsuitable. Shortcomings such as purchase, and there are safety factors (high temperature and explosive), it

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Industrial production method of azilsartan
  • Industrial production method of azilsartan
  • Industrial production method of azilsartan

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0028] Example 1

[0029] The specific operation steps for the production of Azilsartan are as follows:

[0030] 1. Preparation of the compound of formula III:

[0031]

[0032] Add 4.0kg dimethyl sulfoxide, 2.0kg sodium bicarbonate, 1.4kg hydroxylamine hydrochloride, and heat up to about 42±2°C. The stirring reaction is about 2hr, cooled to 25±5°C, centrifuged, the filter cake is washed with 1.4kg dimethyl sulfoxide, the filter cake is discarded, and the filtrate is directly vacuum pumped into the reactor, and the temperature is raised to 45±2°C and added 1.0kg candesartan C6 Alkyl ester (compound represented by formula IV), the temperature was raised to 92±2°C and the reaction was incubated for 12hr. HPLC confirmed that the raw material was less than 1.0%. Cool down to 40°C and add 3.0kg of tap water dropwise, stop dripping when there is turbidity, cool down in a circulating ice-salt bath (cooling in stages, take 1hr) to 10°C, keep stirring for 2hr, centrifuge to obtain...

Example Embodiment

[0040] Example 2

[0041] The specific operation steps for the production of Azilsartan are as follows:

[0042] 1. Preparation of the compound of formula III:

[0043]

[0044] Add 4.0 kg of N-methylpyrrolidone, 1.0 kg of anhydrous sodium carbonate, and 1.3 kg of hydroxylamine hydrochloride, and the temperature is raised to about 30-40 °C. About 2hr of stirring reaction, be cooled to 30 ± 5 ℃, centrifuge, add 1.0kg N-methyl pyrrolidone to wash filter cake, filter cake is discarded, filtrate is directly vacuum pumped into reactor, be warming up to 45 ± 2 ℃ and add 1.0kg candesartan C6 alkyl ester (compound shown in formula IV), the temperature was raised to 95±5°C and the reaction was incubated for 20hr, and HPLC confirmed that the raw material was less than 1%. Cool down to 40°C and add 3.5kg of tap water dropwise, stop dripping when there is turbidity, cool down in a circulating ice-salt bath (cooling in stages, take 1hr) to 10°C, keep stirring for 2hr, centrifuge to ob...

Example Embodiment

[0052] Example 3

[0053] The specific operation steps for the production of Azilsartan are as follows:

[0054] 1. Preparation of the compound of formula III:

[0055]

[0056] Add 4.0kg of N,N-dimethylacetamide, 1.35kg of potassium bicarbonate and 1.4kg of hydroxylamine hydrochloride, and the temperature is raised to about 30-40°C. The reaction was stirred for about 2hr, cooled to 25±5°C, centrifuged, and 1.0kg of N,N-dimethylacetamide was added to wash the filter cake. Candesartan C6 alkyl ester (compound shown in formula IV), heat up to 102±3°C and keep the reaction for 24hr, and HPLC confirms that the raw material is less than 1%. Cool down to 40°C and add 3.2kg of tap water dropwise, stop dripping when there is turbidity, cool down in a circulating ice-salt bath (cooling in stages, take 1hr) to 10°C, keep stirring for 2hr, centrifuge to obtain wet products, return to the kettle for beating once ( 2.0kg of water), centrifuged and dried to obtain 1.0-1.1kg of wet pro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an industrial production method of azilsartan. The method comprises the following steps: 1) replacing hydroxylamine hydrochloride and organic alkali or inorganic alkali in a polarity aprotic solvent and centrifuging to obtain a homogeneous system, adding candesartan C6 alkyl ester (a compound shown in formula IV) and reacting at 90-110 DEG C to obtain a compound shown in formula III; and 2) dissolving the compound shown in formula III and a carbonylation reagent in the polarity aprotic solvent, adding in the organic alkali or inorganic alkali and reacting at 0-40 DEG C to obtain a compound shown in formula II, and carrying out alkaline hydrolysis to obtain azilsartan. By adopting the preparation method, the production cost of azilsartan is greatly reduced, an expensive and unstable hydroxylamine solution is not used, the reaction temperature is lowered, the product quality is well improved, the requirement for medicinal level is met, and individual impurity is controlled below 0.1%, which is superior to the ICH requirement of the EU (European Union).

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical production, and in particular relates to an industrial production method of azilsartan. Background technique [0002] Azilsartan is a new angiotensin II receptor antagonist that lowers blood pressure by blocking the effects of angiotensin II and vasopressor hormones. The drug was launched by Takeda Pharmaceutical Company of Japan in 2012 for the treatment of hypertension. treat. [0003] Chinese patent CN102344415A discloses that replacing hydroxylamine hydrochloride with 50% hydroxylamine solution can increase the yield, but the actual result still has a large amount of amide by-products, and the yield is about 51% to 55%. In addition, the 50% hydroxylamine solution is expensive and unsuitable. There are disadvantages such as purchasing, and there are safety factors (high temperature and explosion), and it is not suitable for industrial production in terms of cost and safety. Chinese pat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D413/10
CPCC07D413/10
Inventor 胡孟奇刘斐孙松
Owner 合肥远志医药科技开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap